Literature DB >> 15793587

Chfr is required for tumor suppression and Aurora A regulation.

Xiaochun Yu1, Katherine Minter-Dykhouse, Liviu Malureanu, Wei-Meng Zhao, Dongwei Zhang, Carolin J Merkle, Irene M Ward, Hideyuki Saya, Guowei Fang, Jan van Deursen, Junjie Chen.   

Abstract

Tumorigenesis is a consequence of loss of tumor suppressors and activation of oncogenes. Expression of the mitotic checkpoint protein Chfr is lost in 20-50% of primary tumors and tumor cell lines. To explore whether downregulation of Chfr contributes directly to tumorigenesis, we generated Chfr knockout mice. Chfr-deficient mice are cancer-prone, develop spontaneous tumors and have increased skin tumor incidence after treatment with dimethylbenz(a)anthracene. Chfr deficiency leads to chromosomal instability in embryonic fibroblasts and regulates the mitotic kinase Aurora A, which is frequently upregulated in a variety of tumors. Chfr physically interacts with Aurora A and ubiquitinates Aurora A both in vitro and in vivo. Collectively, our data suggest that Chfr is a tumor suppressor and ensures chromosomal stability by controlling the expression levels of key mitotic proteins such as Aurora A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793587     DOI: 10.1038/ng1538

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  87 in total

Review 1.  Mitosis in vertebrates: the G2/M and M/A transitions and their associated checkpoints.

Authors:  Conly L Rieder
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

2.  Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA.

Authors:  Gabriella Livide; Maria Carmela Epistolato; Mariangela Amenduni; Vittoria Disciglio; Annabella Marozza; Maria Antonietta Mencarelli; Paolo Toti; Stefano Lazzi; Theodora Hadjistilianou; Sonia De Francesco; Alfonso D'Ambrosio; Alessandra Renieri; Francesca Ariani
Journal:  Pathol Oncol Res       Date:  2012-01-26       Impact factor: 3.201

Review 3.  Ubiquitin and SUMO systems in the regulation of mitotic checkpoints.

Authors:  Gustavo J Gutierrez; Ze'ev Ronai
Journal:  Trends Biochem Sci       Date:  2006-05-02       Impact factor: 13.807

4.  RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly.

Authors:  Michael S Y Huen; Robert Grant; Isaac Manke; Kay Minn; Xiaochun Yu; Michael B Yaffe; Junjie Chen
Journal:  Cell       Date:  2007-11-20       Impact factor: 41.582

5.  Functional interaction between Chfr and Kif22 controls genomic stability.

Authors:  Subbareddy Maddika; Shirley M-H Sy; Junjie Chen
Journal:  J Biol Chem       Date:  2009-03-25       Impact factor: 5.157

6.  p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation.

Authors:  Chun-Chi Wu; Tsung-Ying Yang; Chang-Tze Ricky Yu; Liem Phan; Cristina Ivan; Anil K Sood; Shih-Lan Hsu; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 7.  Spatiotemporal regulation of the Dma1-mediated mitotic checkpoint coordinates mitosis with cytokinesis.

Authors:  Sierra N Cullati; Kathleen L Gould
Journal:  Curr Genet       Date:  2019-01-02       Impact factor: 3.886

8.  CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC.

Authors:  Rathi N Pillai; Seth A Brodie; Gabriel L Sica; You Shaojin; Ge Li; Dana C Nickleach; Liu Yuan; Vijay A Varma; Dacian Bonta; James G Herman; Malcom V Brock; Maria J A Ribeiro; Suresh S Ramalingam; Taofeek K Owonikoko; Fadlo R Khuri; Johann C Brandes
Journal:  Clin Cancer Res       Date:  2013-02-05       Impact factor: 12.531

Review 9.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

10.  Yeast Chfr homologs retard cell cycle at G1 and G2/M via Ubc4 and Ubc13/Mms2-dependent ubiquitination.

Authors:  Greta L Loring; Kathryn C Christensen; Scott A Gerber; Charles Brenner
Journal:  Cell Cycle       Date:  2007-10-02       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.